Institutional review boards or IRBs are some of the biggest enablers of risky, unproven stem cell clinics. We often see statements on stem cell clinic websites to the effect that they have approvals from IRBs so the clinic firms must […]

The post FDA needs to quickly act against IRBs enabling risky fat stem cell clinics appeared first on The Niche.